1. Home
  2. LYRA vs TAIT Comparison

LYRA vs TAIT Comparison

Compare LYRA & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • TAIT
  • Stock Information
  • Founded
  • LYRA 2005
  • TAIT 1989
  • Country
  • LYRA United States
  • TAIT United States
  • Employees
  • LYRA N/A
  • TAIT N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • TAIT Electronic Components
  • Sector
  • LYRA Health Care
  • TAIT Technology
  • Exchange
  • LYRA Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • LYRA 15.0M
  • TAIT 13.1M
  • IPO Year
  • LYRA 2020
  • TAIT 1995
  • Fundamental
  • Price
  • LYRA $9.15
  • TAIT $2.27
  • Analyst Decision
  • LYRA Buy
  • TAIT
  • Analyst Count
  • LYRA 2
  • TAIT 0
  • Target Price
  • LYRA $16.00
  • TAIT N/A
  • AVG Volume (30 Days)
  • LYRA 288.0K
  • TAIT 16.6K
  • Earning Date
  • LYRA 08-13-2025
  • TAIT 08-13-2025
  • Dividend Yield
  • LYRA N/A
  • TAIT 8.81%
  • EPS Growth
  • LYRA N/A
  • TAIT N/A
  • EPS
  • LYRA N/A
  • TAIT 0.01
  • Revenue
  • LYRA $1,185,000.00
  • TAIT $4,260,000.00
  • Revenue This Year
  • LYRA N/A
  • TAIT N/A
  • Revenue Next Year
  • LYRA $1,286.17
  • TAIT N/A
  • P/E Ratio
  • LYRA N/A
  • TAIT $235.11
  • Revenue Growth
  • LYRA N/A
  • TAIT N/A
  • 52 Week Low
  • LYRA $3.81
  • TAIT $2.01
  • 52 Week High
  • LYRA $37.50
  • TAIT $3.05
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 44.26
  • TAIT 57.14
  • Support Level
  • LYRA $8.35
  • TAIT $2.11
  • Resistance Level
  • LYRA $9.36
  • TAIT $2.32
  • Average True Range (ATR)
  • LYRA 1.25
  • TAIT 0.08
  • MACD
  • LYRA -0.72
  • TAIT 0.01
  • Stochastic Oscillator
  • LYRA 9.95
  • TAIT 64.00

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: